Clarity Pharmaceuticals Stock Price on November 27, 2024
| CLRPF Stock | 3.89 0.39 11.14% |
If you're considering investing in Clarity Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Clarity Pharmaceuticals stands at 3.89, as last reported on the 30th of November, with the highest price reaching 4.10 and the lowest price hitting 3.89 during the day. Clarity Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0166, which signifies that the company had a -0.0166% return per unit of standard deviation over the last 3 months. Clarity Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clarity Pharmaceuticals' risk adjusted performance of (0), and Mean Deviation of 3.76 to double-check the risk estimate we provide.
Clarity Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Clarity |
Sharpe Ratio = -0.0166
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLRPF |
Estimated Market Risk
| 5.46 actual daily | 48 52% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Clarity Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clarity Pharmaceuticals by adding Clarity Pharmaceuticals to a well-diversified portfolio.
Related Headline
Hudson Pacific Headline on 27th of November 2024
Acquisition by Christopher Barton of 14128 shares of Hudson ... by Christopher Barton
Filed transaction by Hudson Pacific Properties Officer Evp,development Capital Inv. Grant, award or other acquisition pursuant to Rule 16b-3
Clarity Pharmaceuticals Valuation on November 27, 2024
It is possible to determine the worth of Clarity Pharmaceuticals on a given historical date. On November 27, 2024 Clarity was worth 4.1 at the beginning of the trading date compared to the closed value of 3.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Clarity Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Clarity Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Clarity Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Clarity Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.78 | 3.78 | 3.50 | 3.50 | 27,600 | |
11/27/2024 | 4.10 | 4.10 | 3.89 | 3.89 | 1,400 |
| 4.10 | 4.10 | 3.89 | 3.89 | 0.00 |
| Backtest Clarity Pharmaceuticals | | | Clarity Pharmaceuticals History | Previous | Next |
Clarity Pharmaceuticals Trading Date Momentum on November 27, 2024
| On November 30 2024 Clarity Pharmaceuticals was traded for 3.89 at the closing time. The highest daily price throughout the period was 4.10 and the lowest price was 3.89 . There was no trading activity during the period 0.0. Lack of trading volume on 11/30/2024 did not affect price variability. The overall trading delta to current closing price is 5.40% . |
Price Boundaries
Clarity Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Clarity Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Clarity Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Clarity Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clarity Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Clarity Pharmaceuticals pink sheet market strength indicators, traders can identify Clarity Pharmaceuticals entry and exit signals to maximize returns
Clarity Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Clarity Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Clarity Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Clarity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | (0.15) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Clarity Pink Sheet analysis
When running Clarity Pharmaceuticals' price analysis, check to measure Clarity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clarity Pharmaceuticals is operating at the current time. Most of Clarity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Clarity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clarity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Clarity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |